The promise and paradox of HIV self-testing in the era of twice-yearly PrEP [0.03%]
二次预防时代HIV自我检测的希望与悖论
Victor Abiola Adepoju,Abdulrakib Abdulrahim,Shankar Biswas
Victor Abiola Adepoju
The Lancet Hiv
The Lancet Hiv
Peter Ranscombe
Peter Ranscombe
Fio Trethewey
Fio Trethewey
Roger Pebody
Roger Pebody
A research framework to support re-engagement and continuous engagement in HIV care [0.03%]
支持HIV患者重返和持续接受治疗的研究框架
Marie-Claude C Lavoie,Elvin H Geng
Marie-Claude C Lavoie
Globally, in 2024, 87% of all people living with HIV knew their HIV status, and among people aware of their status and on treatment, 94% were virally suppressed. As progress is being made to reach the UNAIDS 95-95-95 targets, one of the key...
ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study [0.03%]
婴儿期开始抗逆转录病毒治疗后先天性HIV-1感染儿童的ART中断艾滋病缓解研究（IMPAACT P1115）：一项多中心开放标签一期/二期概念验证研究
Deborah Persaud,Anne Coletti,Bryan S Nelson et al.
Deborah Persaud et al.
Background: We hypothesised that initiating antiretroviral therapy (ART) soon after birth could limit HIV-1 reservoirs and promote ART-free remission. This study aims to assess remission in children with in-utero HIV-1 in...
Maria C Puertas
Maria C Puertas
Luxsena Sukumaran,Karine Scheuermaier,Caroline A Sabin et al.
Luxsena Sukumaran et al.
People with HIV experience higher burden of cardiometabolic, mood, and cognitive disorders. Poor-quality and insufficient sleep are both associated with increased risk for these comorbidities and are more common in people with HIV. Although...